Tenjarla[au] - Search Results

Year	Number of Results
1988	1
1991	1
1992	1
1993	1
1995	1
1996	1
1998	3
1999	4
2000	1
2007	1
2010	1
2011	1
2013	2
2014	3
2015	2
2016	1
2017	1
2022	1
2023	1
2024	0

1

Microemulsions: an overview and pharmaceutical applications.

Tenjarla S. Tenjarla S. Crit Rev Ther Drug Carrier Syst. 1999;16(5):461-521. Crit Rev Ther Drug Carrier Syst. 1999. PMID: 10635455 Review.

2

Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.

Salamat-Miller N, Turner MA, Bandekar A, Dixit N, Jochim E, Mangum B, McPherson C, Tenjarla S, Singh S, Hwang YS, Barton N. Salamat-Miller N, et al. Among authors: tenjarla s. World J Pediatr. 2023 Jan;19(1):58-67. doi: 10.1007/s12519-022-00610-9. Epub 2022 Nov 7. World J Pediatr. 2023. PMID: 36344872 Free PMC article.

3

Assessment of value and applications of in vitro testing of topical dermatological drug products.

Flynn GL, Shah VP, Tenjarla SN, Corbo M, DeMagistris D, Feldman TG, Franz TJ, Miran DR, Pearce DM, Sequeira JA, Swarbrick J, Wang JC, Yacobi A, Zatz JL. Flynn GL, et al. Among authors: tenjarla sn. Pharm Res. 1999 Sep;16(9):1325-30. doi: 10.1023/a:1018997520950. Pharm Res. 1999. PMID: 10496646 Free article. Review.

4

Dissolution of Commercially Available Mesalamine Formulations at Various pH Levels.

Tenjarla S. Tenjarla S. Drugs R D. 2015 Jun;15(2):211-5. doi: 10.1007/s40268-015-0097-5. Drugs R D. 2015. PMID: 26115756 Free PMC article.

5

Cutaneous angiosarcoma of the foot: a case report and review of the literature.

Tenjarla S, Sheils LA, Kwiatkowski TM, Chawla S. Tenjarla S, et al. Case Rep Oncol Med. 2014;2014:657876. doi: 10.1155/2014/657876. Epub 2014 Dec 9. Case Rep Oncol Med. 2014. PMID: 25574410 Free PMC article.

6

n-pentyl N-acetylprolinate. A new skin penetration enhancer.

Harris WT, Tenjarla SN, Holbrook JM, Smith J, Mead C, Entrekin J. Harris WT, et al. Among authors: tenjarla sn. J Pharm Sci. 1995 May;84(5):640-2. doi: 10.1002/jps.2600840522. J Pharm Sci. 1995. PMID: 7658358

7

Infliximab Optimization Based on Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.

Hofmekler T, Bertha M, McCracken C, Martineau B, McKinnon E, Schoen BT, McElhanon BO, Tenjarla G, Kugathasan S, Sauer CG. Hofmekler T, et al. Among authors: tenjarla g. J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):580-585. doi: 10.1097/MPG.0000000000001302. J Pediatr Gastroenterol Nutr. 2017. PMID: 28079601

8

Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels.

Abinusawa A, Tenjarla S. Abinusawa A, et al. Among authors: tenjarla s. Adv Ther. 2015 May;32(5):477-84. doi: 10.1007/s12325-015-0206-4. Epub 2015 May 8. Adv Ther. 2015. PMID: 25951927 Free PMC article.

9

A 14-year-old girl with recurrent vulvar abscess.

Bicette R, Tenjarla G, Kugathasan S, Alazraki A, Haddad L. Bicette R, et al. Among authors: tenjarla g. J Pediatr Adolesc Gynecol. 2014 Aug;27(4):e83-6. doi: 10.1016/j.jpag.2013.07.010. Epub 2013 Nov 20. J Pediatr Adolesc Gynecol. 2014. PMID: 24268555

10

High-performance liquid chromatographic assay of prazosin for transdermal screening studies.

Tenjarla SN, Tseggai A. Tenjarla SN, et al. J Clin Pharm Ther. 1992 Feb;17(1):37-42. doi: 10.1111/j.1365-2710.1992.tb01262.x. J Clin Pharm Ther. 1992. PMID: 1548310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year